{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:24:04Z","timestamp":1784046244703,"version":"3.55.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04714-9","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T13:34:21Z","timestamp":1756906461000},"page":"949-965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Precision nanotherapeutics for kidney disease: targeting inflammation and maladaptive repair"],"prefix":"10.1007","volume":"58","author":[{"given":"Peng","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"4714_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semnephrol.2018.10.007","volume":"39","author":"K Singbartl","year":"2019","unstructured":"Singbartl K, Formeck CL, Kellum JA (2019) Kidney-immune system crosstalk in AKI. Semin Nephrol 39:96\u2013106. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.10.007","journal-title":"Semin Nephrol"},{"key":"4714_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Sig Transduct Target Ther 7:182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5","journal-title":"Sig Transduct Target Ther"},{"key":"4714_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","volume":"80","author":"BD Humphreys","year":"2018","unstructured":"Humphreys BD (2018) Mechanisms of renal fibrosis. Annu Rev Physiol 80:309\u2013326. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034227","journal-title":"Annu Rev Physiol"},{"key":"4714_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-physiol-022516-034219","volume":"79","author":"SC Huen","year":"2017","unstructured":"Huen SC, Cantley LG (2017) Macrophages in renal injury and repair. Annu Rev Physiol 79:449\u2013469. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034219","journal-title":"Annu Rev Physiol"},{"key":"4714_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00467-013-2726-y","volume":"30","author":"SC Huen","year":"2015","unstructured":"Huen SC, Cantley LG (2015) Macrophage-mediated injury and repair after ischemic kidney injury. Pediatr Nephrol 30:199\u2013209. https:\/\/doi.org\/10.1007\/s00467-013-2726-y","journal-title":"Pediatr Nephrol"},{"key":"4714_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491. https:\/\/doi.org\/10.3389\/fimmu.2014.00491","journal-title":"Front Immunol"},{"key":"4714_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu N-Q, Szabo AL et al (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513:559\u2013563. https:\/\/doi.org\/10.1038\/nature13490","journal-title":"Nature"},{"key":"4714_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray PJ (2017) Macrophage polarization. Annu Rev Physiol 79:541\u2013566. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034339","journal-title":"Annu Rev Physiol"},{"key":"4714_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593\u2013604. https:\/\/doi.org\/10.1016\/j.immuni.2010.05.007","journal-title":"Immunity"},{"key":"4714_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn TA, Vannella KM (2016) Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44:450\u2013462. https:\/\/doi.org\/10.1016\/j.immuni.2016.02.015","journal-title":"Immunity"},{"key":"4714_CR11","doi-asserted-by":"publisher","first-page":"F477","DOI":"10.1152\/ajprenal.00624.2012","volume":"305","author":"SC Huen","year":"2013","unstructured":"Huen SC, Moeckel GW, Cantley LG (2013) Macrophage-specific deletion of transforming growth factor-\u03b21 does not prevent renal fibrosis after severe ischemia-reperfusion or obstructive injury. Am J Physiol Renal Physiol 305:F477\u2013F484. https:\/\/doi.org\/10.1152\/ajprenal.00624.2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"4714_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159\u2013175. https:\/\/doi.org\/10.1038\/nri3399","journal-title":"Nat Rev Immunol"},{"key":"4714_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13054-016-1250-4","volume":"20","author":"PHC Leliefeld","year":"2016","unstructured":"Leliefeld PHC, Wessels CM, Leenen LPH et al (2016) The role of neutrophils in immune dysfunction during severe inflammation. Crit Care 20:73. https:\/\/doi.org\/10.1186\/s13054-016-1250-4","journal-title":"Crit Care"},{"key":"4714_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.it.2023.07.001","volume":"44","author":"HW Kuhn","year":"2023","unstructured":"Kuhn HW, Hreha TN, Hunstad DA (2023) Immune defenses in the urinary tract. Trends Immunol 44:701\u2013711. https:\/\/doi.org\/10.1016\/j.it.2023.07.001","journal-title":"Trends Immunol"},{"key":"4714_CR15","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3390\/toxins7083245","volume":"7","author":"RK Tadagavadi","year":"2015","unstructured":"Tadagavadi RK, Gao G, Wang WW, Gonzalez MR, Reeves WB (2015) Dendritic cell protection from cisplatin nephrotoxicity is independent of neutrophils. Toxins 7:3245\u20133256. https:\/\/doi.org\/10.3390\/toxins7083245","journal-title":"Toxins"},{"key":"4714_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","volume":"31","author":"M Merad","year":"2013","unstructured":"Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563\u2013604. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-074950","journal-title":"Annu Rev Immunol"},{"key":"4714_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41581-020-0272-y","volume":"16","author":"C Kurts","year":"2020","unstructured":"Kurts C, Ginhoux F, Panzer U (2020) Kidney dendritic cells: fundamental biology and functional roles in health and disease. Nat Rev Nephrol 16:391\u2013407. https:\/\/doi.org\/10.1038\/s41581-020-0272-y","journal-title":"Nat Rev Nephrol"},{"key":"4714_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1681\/ASN.2009040407","volume":"21","author":"RK Tadagavadi","year":"2010","unstructured":"Tadagavadi RK, Reeves WB (2010) Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J Am Soc Nephrol 21:53\u201363. https:\/\/doi.org\/10.1681\/ASN.2009040407","journal-title":"J Am Soc Nephrol"},{"key":"4714_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238816","volume":"15","author":"WW Wang","year":"2020","unstructured":"Wang WW, Wang Y, Li K et al (2020) IL-10 from dendritic cells but not from T regulatory cells protects against cisplatin-induced nephrotoxicity. PLoS ONE 15:e0238816. https:\/\/doi.org\/10.1371\/journal.pone.0238816","journal-title":"PLoS ONE"},{"key":"4714_CR20","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1681\/ASN.2013050528","volume":"25","author":"OP Kulkarni","year":"2014","unstructured":"Kulkarni OP, Hartter I, Mulay SR et al (2014) Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J Am Soc Nephrol 25:978\u2013989. https:\/\/doi.org\/10.1681\/ASN.2013050528","journal-title":"J Am Soc Nephrol"},{"key":"4714_CR21","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1113\/JP286756","volume":"603","author":"S Hubbi","year":"2025","unstructured":"Hubbi S, Hao S, Epps J, Ferreri NR (2025) Tumour necrosis factor-alpha at the intersection of renal epithelial and immune cell function. J Physiol 603:2915\u20132936. https:\/\/doi.org\/10.1113\/JP286756","journal-title":"J Physiol"},{"key":"4714_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13:227\u2013242. https:\/\/doi.org\/10.1038\/nri3405","journal-title":"Nat Rev Immunol"},{"key":"4714_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-94-017-9487-9_2","volume":"841","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Zhang Y, Gu W, Sun B (2014) TH1\/TH2 cell differentiation and molecular signals. Adv Exp Med Biol 841:15\u201344. https:\/\/doi.org\/10.1007\/978-94-017-9487-9_2","journal-title":"Adv Exp Med Biol"},{"key":"4714_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110307","volume":"119","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang Y, Shou S, Jin H (2023) The role of IL-17 in acute kidney injury. Int Immunopharmacol 119:110307. https:\/\/doi.org\/10.1016\/j.intimp.2023.110307","journal-title":"Int Immunopharmacol"},{"key":"4714_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.4430","volume":"235","author":"X Peng","year":"2015","unstructured":"Peng X, Xiao Z, Zhang J et al (2015) IL-17A produced by both \u03b3\u03b4 t and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J Pathol 235:79\u201389. https:\/\/doi.org\/10.1002\/path.4430","journal-title":"J Pathol"},{"key":"4714_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130651","volume":"5","author":"F Do Valle Duraes","year":"2020","unstructured":"Do Valle Duraes F, Lafont A, Beibel M et al (2020) Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight 5:e130651. https:\/\/doi.org\/10.1172\/jci.insight.130651","journal-title":"JCI Insight"},{"key":"4714_CR27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"The Accelerating Medicines Partnership in SLE network, Arazi A, Rao DA et al (2019) The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol 20:902\u2013914. https:\/\/doi.org\/10.1038\/s41590-019-0398-x","journal-title":"Nat Immunol"},{"key":"4714_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nri1838","volume":"6","author":"JC Edwards","year":"2006","unstructured":"Edwards JC, Cambridge G (2006) B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6:394\u2013403. https:\/\/doi.org\/10.1038\/nri1838","journal-title":"Nat Rev Immunol"},{"key":"4714_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1681\/ASN.2009020182","volume":"21","author":"HR Jang","year":"2010","unstructured":"Jang HR, Gandolfo MT, Ko GJ et al (2010) B cells limit repair after ischemic acute kidney injury. J Am Soc Nephrol 21:654\u2013665. https:\/\/doi.org\/10.1681\/ASN.2009020182","journal-title":"J Am Soc Nephrol"},{"key":"4714_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/j.1600-6143.2005.00815.x","volume":"5","author":"MJ Burne-Taney","year":"2005","unstructured":"Burne-Taney MJ, Yokota-Ikeda N, Rabb H (2005) Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury. Am J Transplant 5:1186\u20131193. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00815.x","journal-title":"Am J Transplant"},{"key":"4714_CR31","first-page":"157","volume":"504","author":"XD Li","year":"2013","unstructured":"Li XD, Sun L, Chen X et al (2013) Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates type i interferon signalling. Nature 504:157\u2013161","journal-title":"Nature"},{"key":"4714_CR32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/cr.2013.98","volume":"23","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F et al (2013) Cyclic GMP-AMP synthase is a cytosolic DNA sensor that triggers type I interferon-mediated innate immunity. Cell Res 23:1025\u20131032","journal-title":"Cell Res"},{"key":"4714_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21:548\u2013569. https:\/\/doi.org\/10.1038\/s41577-021-00524-z","journal-title":"Nat Rev Immunol"},{"key":"4714_CR34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"M Motwani","year":"2019","unstructured":"Motwani M, Pesiridis S, Fitzgerald KA (2019) DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Immunol 19:369\u2013381","journal-title":"Nat Rev Immunol"},{"key":"4714_CR35","first-page":"6644268","volume":"2021","author":"X Ma","year":"2021","unstructured":"Ma X, Zhang J, Chen M et al (2021) Blockade of cGAS\u2013STING pathway protects against cisplatin-induced acute kidney injury. Oxid Med Cell Longev 2021:6644268","journal-title":"Oxid Med Cell Longev"},{"key":"4714_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1681\/ASN.2019080790","volume":"31","author":"L Liu","year":"2020","unstructured":"Liu L, Lu H, Lu Y et al (2020) Sting activation in tubular epithelial cells promotes renal ischemia-reperfusion injury. J Am Soc Nephrol 31:50\u201365. https:\/\/doi.org\/10.1681\/ASN.2019080790","journal-title":"J Am Soc Nephrol"},{"key":"4714_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.843399","volume":"13","author":"Y Luo","year":"2022","unstructured":"Luo Y, Li M, Xu Y et al (2022) The cGAS-STING pathway: a novel target for chronic kidney disease. Front Immunol 13:843399. https:\/\/doi.org\/10.3389\/fimmu.2022.843399","journal-title":"Front Immunol"},{"key":"4714_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrneph.2015.3","volume":"11","author":"DA Ferenbach","year":"2015","unstructured":"Ferenbach DA, Bonventre JV (2015) Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol 11:264\u2013276. https:\/\/doi.org\/10.1038\/nrneph.2015.3","journal-title":"Nat Rev Nephrol"},{"key":"4714_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","volume":"93","author":"B-C Liu","year":"2018","unstructured":"Liu B-C, Tang T-T, Lv L-L, Lan H-Y (2018) Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int 93:568\u2013579. https:\/\/doi.org\/10.1016\/j.kint.2017.09.033","journal-title":"Kidney Int"},{"key":"4714_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.34067\/KID.0000000000000376","volume":"5","author":"B Maryam","year":"2024","unstructured":"Maryam B, Smith ME, Miller SJ, Natarajan H, Zimmerman KA (2024) Macrophage ontogeny, phenotype, and function in ischemia reperfusion-induced injury and repair. Kidney360 5:459\u2013470. https:\/\/doi.org\/10.34067\/KID.0000000000000376","journal-title":"Kidney360"},{"key":"4714_CR41","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1172\/JCI81166","volume":"125","author":"J-H Baek","year":"2015","unstructured":"Baek J-H, Zeng R, Weinmann-Menke J et al (2015) IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease. J Clin Invest 125:3198\u20133214. https:\/\/doi.org\/10.1172\/JCI81166","journal-title":"J Clin Invest"},{"key":"4714_CR42","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1681\/ASN.2017050523","volume":"29","author":"L-L Lv","year":"2018","unstructured":"Lv L-L, Feng Y, Wen Y et al (2018) Exosomal CCL2 from tubular epithelial cells is critical for albumin-induced tubulointerstitial inflammation. JASN 29:919\u2013935. https:\/\/doi.org\/10.1681\/ASN.2017050523","journal-title":"JASN"},{"key":"4714_CR43","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121:4210\u20134221. https:\/\/doi.org\/10.1172\/JCI45161","journal-title":"J Clin Invest"},{"key":"4714_CR44","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ndt\/gfad238","volume":"39","author":"ME Jacobs","year":"2024","unstructured":"Jacobs ME, de Vries DK, Engelse MA, Dumas SJ, Rabelink TJ (2024) Endothelial to mesenchymal transition in kidney fibrosis. Nephrol Dial Transplant 39:752\u2013760. https:\/\/doi.org\/10.1093\/ndt\/gfad238","journal-title":"Nephrol Dial Transplant"},{"key":"4714_CR45","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41581-021-00474-8","volume":"17","author":"S Avraham","year":"2021","unstructured":"Avraham S, Korin B, Chung J-J et al (2021) The mesangial cell \u2014 the glomerular stromal cell. Nat Rev Nephrol 17:855\u2013864. https:\/\/doi.org\/10.1038\/s41581-021-00474-8","journal-title":"Nat Rev Nephrol"},{"key":"4714_CR46","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3390\/cells8111361","volume":"8","author":"R Gupta","year":"2019","unstructured":"Gupta R, Sharma M (2019) Mesangial cells in diabetic nephropathy: a comprehensive review. Cells 8:1361. https:\/\/doi.org\/10.3390\/cells8111361","journal-title":"Cells"},{"key":"4714_CR47","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1681\/ASN.2008050549","volume":"20","author":"D Schl\u00f6ndorff","year":"2009","unstructured":"Schl\u00f6ndorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20:1179\u20131187. https:\/\/doi.org\/10.1681\/ASN.2008050549","journal-title":"J Am Soc Nephrol"},{"key":"4714_CR48","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1681\/ASN.2012020133","volume":"24","author":"A Goldwich","year":"2013","unstructured":"Goldwich A, Burkard M, \u00d6lke M et al (2013) Podocytes are nonhematopoietic professional antigen-presenting cells. J Am Soc Nephrol 24:906\u2013916. https:\/\/doi.org\/10.1681\/ASN.2012020133","journal-title":"J Am Soc Nephrol"},{"key":"4714_CR49","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.7150\/thno.43145","volume":"10","author":"C Xu","year":"2020","unstructured":"Xu C, Zhou X, Xie T et al (2020) Renal tubular Bim mediates the tubule-podocyte crosstalk via NFAT2 to induce podocyte cytoskeletal dysfunction. Theranostics 10:6806\u20136824. https:\/\/doi.org\/10.7150\/thno.43145","journal-title":"Theranostics"},{"key":"4714_CR50","doi-asserted-by":"publisher","first-page":"F947","DOI":"10.1152\/ajprenal.90601.2008","volume":"296","author":"SC Satchell","year":"2009","unstructured":"Satchell SC, Braet F (2009) Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 296:F947\u2013F956. https:\/\/doi.org\/10.1152\/ajprenal.90601.2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"4714_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","volume":"17","author":"RW Naylor","year":"2021","unstructured":"Naylor RW, Morais MRPT, Lennon R (2021) Complexities of the glomerular basement membrane. Nat Rev Nephrol 17:112\u2013127. https:\/\/doi.org\/10.1038\/s41581-020-0329-y","journal-title":"Nat Rev Nephrol"},{"key":"4714_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/med.21532","volume":"39","author":"CP Liu","year":"2019","unstructured":"Liu CP, Hu Y, Lin JC, Fu HL, Lim LY, Yuan ZX (2019) Targeting strategies for drug delivery to the kidney: from renal glomeruli to tubules. Med Res Rev 39:561\u2013578. https:\/\/doi.org\/10.1002\/med.21532","journal-title":"Med Res Rev"},{"key":"4714_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119679","volume":"587","author":"Z Chen","year":"2020","unstructured":"Chen Z, Peng H, Zhang C (2020) Advances in kidney-targeted drug delivery systems. Int J Pharm 587:119679. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119679","journal-title":"Int J Pharm"},{"key":"4714_CR54","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1073\/pnas.1103573108","volume":"108","author":"CH Choi","year":"2011","unstructured":"Choi CH, Zuckerman JE, Webster P, Davis ME (2011) Targeting kidney mesangium by nanoparticles of defined size. Proc Natl Acad Sci U S A 108:6656\u20136661. https:\/\/doi.org\/10.1073\/pnas.1103573108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4714_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104404","volume":"83","author":"L Yuan","year":"2023","unstructured":"Yuan L, Chen Q, Riviere JE, Lin Z (2023) Pharmacokinetics and tumor delivery of nanoparticles. J Drug Deliv Sci Technol 83:104404. https:\/\/doi.org\/10.1016\/j.jddst.2023.104404","journal-title":"J Drug Deliv Sci Technol"},{"key":"4714_CR56","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2217\/17435889.3.5.703","volume":"3","author":"M Longmire","year":"2008","unstructured":"Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3:703\u2013717. https:\/\/doi.org\/10.2217\/17435889.3.5.703","journal-title":"Nanomedicine"},{"key":"4714_CR57","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/nat.2020.088","volume":"31","author":"S Gangopadhyay","year":"2021","unstructured":"Gangopadhyay S, Nikam RR, Gore KR (2021) Folate receptor-mediated siRNA delivery: recent developments and future directions for RNAi therapeutics. Nucleic Acid Ther 31:245\u2013270. https:\/\/doi.org\/10.1089\/nat.2020.088","journal-title":"Nucleic Acid Ther"},{"key":"4714_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","volume":"89","author":"R Nielsen","year":"2016","unstructured":"Nielsen R, Christensen EI, Birn H (2016) Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int 89:58\u201367. https:\/\/doi.org\/10.1016\/j.kint.2015.11.007","journal-title":"Kidney Int"},{"key":"4714_CR59","doi-asserted-by":"publisher","first-page":"25511","DOI":"10.1021\/acsami.8b07129","volume":"10","author":"Y Feng","year":"2018","unstructured":"Feng Y, Chen H, Shao B et al (2018) Renal-clearable peptide-functionalized Ba2GdF7 nanoparticles for positive tumor-targeting dual-mode bioimaging. ACS Appl Mater Interfaces 10:25511\u201325518. https:\/\/doi.org\/10.1021\/acsami.8b07129","journal-title":"ACS Appl Mater Interfaces"},{"key":"4714_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138870","volume":"10","author":"GR Visweswaran","year":"2015","unstructured":"Visweswaran GR, Gholizadeh S, Ruiters MH et al (2015) Targeting rapamycin to podocytes using a vascular cell adhesion molecule-1 (VCAM-1)-harnessed SAINT-based lipid carrier system. PLoS ONE 10:e0138870. https:\/\/doi.org\/10.1371\/journal.pone.0138870","journal-title":"PLoS ONE"},{"key":"4714_CR61","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-chembioeng-060713-040447","volume":"5","author":"NS Oltra","year":"2014","unstructured":"Oltra NS, Nair P, Discher DE (2014) From stealthy polymersomes and filomicelles to \u201cself\u201d peptide-nanoparticles for cancer therapy. Annu Rev Chem Biomol Eng 5:281\u2013299. https:\/\/doi.org\/10.1146\/annurev-chembioeng-060713-040447","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"4714_CR62","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1039\/d0bm00581a","volume":"8","author":"H Liu","year":"2020","unstructured":"Liu H, Zhang H, Yin N et al (2020) Sialic acid-modified dexamethasone lipid calcium phosphate gel core nanoparticles for target treatment of kidney injury. Biomater Sci 8:3871\u20133884. https:\/\/doi.org\/10.1039\/d0bm00581a","journal-title":"Biomater Sci"},{"key":"4714_CR63","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nnano.2007.70","volume":"2","author":"Y Geng","year":"2007","unstructured":"Geng Y, Dalhaimer P, Cai S et al (2007) Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2:249\u2013255. https:\/\/doi.org\/10.1038\/nnano.2007.70","journal-title":"Nat Nanotechnol"},{"key":"4714_CR64","volume-title":"Macrophage targeted delivery systems","author":"N Singh","year":"2022","unstructured":"Singh N et al (2022) Surface modification of nanoparticles for macrophage targeting. In: Gupta S, Pathak YV (eds) Macrophage targeted delivery systems. Springer, Cham"},{"key":"4714_CR65","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","volume":"81","author":"C Lennicke","year":"2021","unstructured":"Lennicke C, Cochem\u00e9 HM (2021) Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol Cell 81:3691\u20133707. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.018","journal-title":"Mol Cell"},{"key":"4714_CR66","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/biom11081144","volume":"11","author":"AK Aranda-Rivera","year":"2021","unstructured":"Aranda-Rivera AK, Cruz-Gregorio A, Aparicio-Trejo OE, Pedraza-Chaverri J (2021) Mitochondrial redox signaling and oxidative stress in kidney diseases. Biomolecules 11:1144. https:\/\/doi.org\/10.3390\/biom11081144","journal-title":"Biomolecules"},{"key":"4714_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101002","volume":"25","author":"X Han","year":"2024","unstructured":"Han X, Bi L, Yan J et al (2024) Mesoscale size-promoted targeted therapy for acute kidney injury through combined RONS scavenging and inflammation alleviation strategy. Mater Today Bio 25:101002. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101002","journal-title":"Mater Today Bio"},{"key":"4714_CR68","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1021\/acs.nanolett.1c01044","volume":"21","author":"Q Chen","year":"2021","unstructured":"Chen Q, Ding F, Zhang S et al (2021) Sequential therapy of acute kidney injury with a DNA nanodevice. Nano Lett 21:4394\u20134402. https:\/\/doi.org\/10.1021\/acs.nanolett.1c01044","journal-title":"Nano Lett"},{"key":"4714_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101498","volume":"8","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang L, Li J et al (2021) Redox-mediated artificial non-enzymatic antioxidant MXene nanoplatforms for acute kidney injury alleviation. Adv Sci 8:2101498. https:\/\/doi.org\/10.1002\/advs.202101498","journal-title":"Adv Sci"},{"key":"4714_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2020.127371","volume":"409","author":"D-Y Zhang","year":"2021","unstructured":"Zhang D-Y, Liu H, Younis MR et al (2021) Ultrasmall platinum nanozymes as broad-spectrum antioxidants for theranostic application in acute kidney injury. Chem Eng J 409:127371. https:\/\/doi.org\/10.1016\/j.cej.2020.127371","journal-title":"Chem Eng J"},{"key":"4714_CR71","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.7150\/thno.40395","volume":"10","author":"H Yu","year":"2020","unstructured":"Yu H, Jin F, Liu D et al (2020) ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics 10:2342\u20132357. https:\/\/doi.org\/10.7150\/thno.40395","journal-title":"Theranostics"},{"key":"4714_CR72","doi-asserted-by":"publisher","first-page":"9904","DOI":"10.7150\/thno.66518","volume":"11","author":"DY Zhang","year":"2021","unstructured":"Zhang DY, Tu T, Younis MR et al (2021) Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury. Theranostics 11:9904\u20139917. https:\/\/doi.org\/10.7150\/thno.66518","journal-title":"Theranostics"},{"key":"4714_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101794","volume":"32","author":"X Huang","year":"2025","unstructured":"Huang X, Zhang F, Yang Y et al (2025) Curcumin-copper complex nanoparticles as antioxidant nanozymes for acute kidney injury alleviation. Mater Today Bio 32:101794. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101794","journal-title":"Mater Today Bio"},{"key":"4714_CR74","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12951-021-01006-z","volume":"19","author":"DY Zhang","year":"2021","unstructured":"Zhang DY, Liu H, Zhu KS et al (2021) Prussian blue-based theranostics for ameliorating acute kidney injury. J Nanobiotechnol 19:266. https:\/\/doi.org\/10.1186\/s12951-021-01006-z","journal-title":"J Nanobiotechnol"},{"key":"4714_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201904833","volume":"29","author":"T Sun","year":"2019","unstructured":"Sun T, Jiang D, Rosenkrans ZT et al (2019) A melanin-based natural antioxidant defense nanosystem for theranostic application in acute kidney injury. Adv Funct Mater 29:1904833. https:\/\/doi.org\/10.1002\/adfm.201904833","journal-title":"Adv Funct Mater"},{"key":"4714_CR76","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.apsb.2020.03.013","volume":"10","author":"Y Zou","year":"2020","unstructured":"Zou Y, Han Y, Zhang W et al (2020) Strategies for kidney-targeted drug delivery. Acta Pharm Sin B 10:1579\u20131594. https:\/\/doi.org\/10.1016\/j.apsb.2020.03.013","journal-title":"Acta Pharm Sin B"},{"key":"4714_CR77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.actbio.2020.01.034","volume":"104","author":"Z Liu","year":"2020","unstructured":"Liu Z, Liu X, Yang Q et al (2020) Neutrophil membrane-enveloped nanoparticles for the amelioration of renal ischemia-reperfusion injury in mice. Acta Biomater 104:158\u2013166. https:\/\/doi.org\/10.1016\/j.actbio.2020.01.034","journal-title":"Acta Biomater"},{"key":"4714_CR78","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.kint.2020.01.036","volume":"98","author":"SJ Han","year":"2020","unstructured":"Han SJ, Williams RM, D\u2019Agati V et al (2020) Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury. Kidney Int 98:76\u201387. https:\/\/doi.org\/10.1016\/j.kint.2020.01.036","journal-title":"Kidney Int"},{"key":"4714_CR79","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s42003-021-02517-5","volume":"4","author":"A Adhikari","year":"2021","unstructured":"Adhikari A, Mondal S, Chatterjee T et al (2021) Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice. Commun Biol 4:1013. https:\/\/doi.org\/10.1038\/s42003-021-02517-5","journal-title":"Commun Biol"},{"key":"4714_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2020.09.043","volume":"14","author":"Y Yu","year":"2021","unstructured":"Yu Y, Gao J, Jiang L, Wang J (2021) Antidiabetic nephropathy effects of synthesized gold nanoparticles through mitigation of oxidative stress. Arab J Chem 14:103007. https:\/\/doi.org\/10.1016\/j.arabjc.2020.09.043","journal-title":"Arab J Chem"},{"key":"4714_CR81","doi-asserted-by":"publisher","first-page":"37330","DOI":"10.1021\/acsami.2c09538","volume":"14","author":"M Yu","year":"2022","unstructured":"Yu M, Wang D, Zhong D et al (2022) Adropin carried by reactive oxygen species-responsive nanocapsules ameliorates renal lipid toxicity in diabetic mice. ACS Appl Mater Interfaces 14:37330\u201337344. https:\/\/doi.org\/10.1021\/acsami.2c09538","journal-title":"ACS Appl Mater Interfaces"},{"key":"4714_CR82","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.7150\/thno.50654","volume":"11","author":"K Fan","year":"2021","unstructured":"Fan K, Zeng L, Guo J et al (2021) Visualized podocyte-targeting and focused ultrasound responsive glucocorticoid nano-delivery system against immune-associated nephropathy without glucocorticoid side effect. Theranostics 11:2670\u20132690. https:\/\/doi.org\/10.7150\/thno.50654","journal-title":"Theranostics"},{"key":"4714_CR83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12951-021-00845-x","volume":"19","author":"CS Kim","year":"2021","unstructured":"Kim CS, Mathew AP, Vasukutty A et al (2021) Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis. J Nanobiotechnol 19:109. https:\/\/doi.org\/10.1186\/s12951-021-00845-x","journal-title":"J Nanobiotechnol"},{"key":"4714_CR84","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb3900","volume":"6","author":"R Ganugula","year":"2020","unstructured":"Ganugula R, Arora M, Zou D et al (2020) A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus. Sci Adv 6:eabb3900. https:\/\/doi.org\/10.1126\/sciadv.abb3900","journal-title":"Sci Adv"},{"key":"4714_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.101631","volume":"47","author":"H Li","year":"2022","unstructured":"Li H, Tan X, Liu Y et al (2022) Ruxolitinib-loaded black phosphorus nanosheets actively target proximal tubule cells to ameliorate nephrotic syndrome by reducing inflammation and oxidative stress. Nano Today 47:101631. https:\/\/doi.org\/10.1016\/j.nano.2022.101631","journal-title":"Nano Today"},{"key":"4714_CR86","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jconrel.2023.01.018","volume":"354","author":"T-Y Lee","year":"2023","unstructured":"Lee T-Y, Lu H-H, Cheng H-T et al (2023) Delivery of nitric oxide with a pH-responsive nanocarrier for the treatment of renal fibrosis. J Control Release 354:417\u2013428. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.018","journal-title":"J Control Release"},{"key":"4714_CR87","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1080\/10717544.2021.1997327","volume":"28","author":"Y Feng","year":"2021","unstructured":"Feng Y, He X, Zhang Y et al (2021) Metformin-loaded RTEC-targeted nanoparticles for the treatment of renal fibrosis. Drug Deliv 28:2018\u20132029. https:\/\/doi.org\/10.1080\/10717544.2021.1997327","journal-title":"Drug Deliv"},{"issue":"33","key":"4714_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz0748","volume":"6","author":"TT Tang","year":"2020","unstructured":"Tang TT, Wang B, Wu M et al (2020) Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI. Sci Adv 6(33):eaaz0748. https:\/\/doi.org\/10.1126\/sciadv.aaz0748","journal-title":"Sci Adv"},{"issue":"31","key":"4714_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202633","volume":"9","author":"J Lin","year":"2022","unstructured":"Lin J, Lv J, Yu S, Chen Y, Wang H, Chen J (2022) Transcript engineered extracellular vesicles alleviate alloreactive dynamics in renal transplantation. Adv Sci 9(31):2202633. https:\/\/doi.org\/10.1002\/advs.202202633","journal-title":"Adv Sci"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04714-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04714-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04714-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:30:52Z","timestamp":1772029852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04714-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":89,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4714"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04714-9","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable. This article is a review based on previously published literature and did not involve any new studies on human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}